Abstract: Brain metastasis of non-small cell lung cancer (NSCLC) with driver gene mutation is becoming a clinical highlight. Rational combination and sequencing of different treatment methods are of great significance for prolonging the survival time and improving the quality of life of patients. Experts from the Committee of Brain Metastases, Shanghai Anti-Cancer Association have formulated this consensus to standardize the diagnosis and treatment of brain metastasis from NSCLC with driver gene mutation.

Key words: Non-small cell lung cancer, Driver gene mutation, Targeted therapy, Radiotherapy